Effexor XR

DRUG5 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer, University of Ottawa

Conditions

DepressionHealthyMajor Depressive Disorder

Phase 1

Comparison of the Pharmacokinetics of Two Generic Antidepressants and Their Respective Brand Preparations

CompletedNCT00676039

University of OttawaHealthy

Start: 2007-11-30End: 2008-07-31Updated: 2009-02-11

Phase 3

Study Evaluating Effexor XR in Elderly Patients With Major Depression.

CompletedNCT00225485

Wyeth is now a wholly owned subsidiary of PfizerDepression

Start: 2003-12-31Target: 100Updated: 2007-05-28

Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.

CompletedNCT00225524

Wyeth is now a wholly owned subsidiary of PfizerDepression

Start: 2004-09-30Target: 150Updated: 2007-05-24

Study Evaluating Effexor XR for Major Depression.

CompletedNCT00225511

Wyeth is now a wholly owned subsidiary of PfizerDepression

Start: 2004-06-30Target: 590Updated: 2007-05-24

Phase 4

Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder

WithdrawnNCT00878748

Wyeth is now a wholly owned subsidiary of PfizerMajor Depressive Disorder

Start: 2009-04-30End: 2011-10-31Updated: 2021-08-20

Related Papers

Comparison of pharmacokinetic profiles of brand-name and generic formulations of citalopram and venlafaxine: a crossover study.

2009-07-0121 citations